Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects

被引：16
作者：
Sotiropoulos A. [1 ]
Papazafiropoulou A. [1 ]
Apostolou O. [1 ]
Kokolaki A. [1 ]
Gikas A. [2 ]
Pappas S. [1 ]
机构：
[1] 3rd Department of Internal Medicine, Center of Diabetes, General Hospital of Nikaia Saint Panteleimon, Piraeus
[2] Department of General Practice, Health Centre of Kalivia, Kalivia-Lagonisi, Athens
来源：
BMC Research Notes | / 1卷 / 1期
关键词：
Depressive Symptom; Beck Depression Inventory; Diabetic Subject; Poor Glycemic Control; Macrovascular Disease;
D O I：
10.1186/1756-0500-1-101
中图分类号：
学科分类号：
摘要：
Background. Depression is common among diabetic subjects. We conducted the present study to estimate the prevalence of depression in subjects with type 2 diabetes (T2D) in Greece. Methods. The study sample consisted of 320 T2D subjects without overt macrovascular disease attending the diabetes outpatient clinic of our hospital, from June 2007 to December 2007. Depressive symptoms were measured using the 21-item Beck Depression Inventory, modified for use in diabetic subjects. Results. Of the study subjects 107 (33.4%) reported elevated depressive symptoms. More women than men with diabetes reported symptoms of depression (48.4% vs. 12.7%, P < 0.001). In the female study group, depressive symptoms were correlated with HbA1c(P = 0.04), and duration of diabetes (P = 0.004). In the male study group, univariate linear regression analysis showed no significant relationships between depressive symptoms and the testing variables. Conclusion. The prevalence of depression in Greek T2D subjects is high. Diabetic female subjects showed increased levels of depressive symptoms compared with male subjects. Independent risk factors of depressive symptoms in diabetic female subjects were diabetes duration and glycemic control. © 2008 Sotiropoulos et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 37 条
[1]  
Gavard J.A., Lustman P.J., Clouse R.E., Prevalence of depression in adults with diabetes. An epidemiological evaluation, Diabetes Care, 16, pp. 1167-1178, (1993)
[2]  
Katon W., Von Korff M., Ciechanowski P., Russo J., Lin E., Simon G., Ludman E., Walker E., Bush T., Young B., Behavioral and clinical factors associated with depression among individuals with diabetes, Diabetes Care, 27, pp. 914-920, (2004)
[3]  
Lin E.H., Katon W., Von Korff M., Rutter C., Simon G.E., Oliver M., Ciechanowski P., Ludman E.J., Bush T., Young B., Relationship of depression and diabetes self-care, medication adherence, and preventive care, Diabetes Care, 27, pp. 2154-2160, (2004)
[4]  
Lustman P.J., Anderson R.J., Freedland K.E., De Groot M., Carney R.M., Clouse R.E., Depression and poor glycemic control: A meta-analytic review of the literature, Diabetes Care, 23, pp. 934-942, (2000)
[5]  
Black S.A., Markides K.S., Ray L.A., Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes, Diabetes Care, 26, pp. 2822-2828, (2003)
[6]  
Katon W.J., Rutter C., Simon G., Lin E.H.B., Ludman E., Ciechanowski P., Kinder L., Young B., Von Korff M., The association of comorbid depression with mortality in patients with type 2 diabetes, Diabetes Care, 28, 11, pp. 2668-2672, (2005)
[7]  
Carney C., Diabetes mellitus and major depressive disorder: An overview of prevalence, complications, and treatment, Depress Anxiety, 7, pp. 149-157, (1998)
[8]  
Lustman P.J., Griffith L.S., Gavard J.A., Clouse R.E., Depression in adults with diabetes, Diabetes Care, 15, pp. 1631-1639, (1992)
[9]  
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 24, (2001)
[10]  
Nethan D.M., Singer D.E., Hursthal K., The clinical information value of the glycosylated hemoglobin assay, N Engl J Med, 310, pp. 341-346, (1984)
1234